InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Cooper Graham K, Directeur. Insider active across 1 company, notably Beam Therapeutics Inc.. Aggregated, 2 reports have been recorded. Activity tracked since 28 June 2021. The latest transaction was disclosed on 6 July 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Cooper Graham K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,614 shares@ US$17.0018.0% of flowCommon StockSEC:0000899243-21-027902:0
12,045 shares@ US$17.0082.0% of flowCommon StockSEC:0000899243-21-026782:0
2 of 2 declarations
About Cooper Graham K
Graham K. Cooper is a Director at Beam Therapeutics Inc. He plays a key role in the governance of the company, bringing his expertise to guide strategic decisions.
